NASDAQ:BIOC - Biocept Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$6.23 -0.25 (-3.86 %)
(As of 07/20/2018 02:01 PM ET)
Previous Close$6.23
Today's Range$6.15 - $6.40
52-Week Range$3.50 - $44.55
Volume7,835 shs
Average Volume1.24 million shs
Market Capitalization$14.31 million
P/E Ratio-0.27
Dividend YieldN/A
Beta1.89

Analyst Ratings

Biocept (NASDAQ:BIOC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Biocept in the last 12 months. Their average twelve-month price target is $1.25, suggesting that the stock has a possible downside of 79.94%. The high price target for BIOC is $1.50 and the low price target for BIOC is $1.00. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.502.503.003.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $1.25$1.25$1.25$2.25
Price Target Upside: 79.94% downside594.44% upside420.83% upside251.56% upside

Biocept (NASDAQ:BIOC) Consensus Price Target History

Price Target History for Biocept (NASDAQ:BIOC)

Biocept (NASDAQ:BIOC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/23/2018Westpark CapitalDowngradeOutperform ➝ HoldLowView Rating Details
11/14/2017Chardan CapitalReiterated RatingBuy ➝ Buy$2.50 ➝ $1.50N/AView Rating Details
3/13/2017Roth CapitalReiterated RatingBuy$1.60 ➝ $3.00LowView Rating Details
11/10/2016Feltl & Co.UpgradeHold ➝ Buy$2.00N/AView Rating Details
8/31/2016Rodman & RenshawSet Price TargetBuy$2.50N/AView Rating Details
(Data available from 7/20/2016 forward)
This page was last updated on 7/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.